Xenon pharmaceuticals inc.

Major-Pharmaceuticals

XENE


200 ? 3650 Gilmore Way
Burnaby , BC V5G 4W8

Executive/
Director

Price

  • Last Close
  • $ 41.35
    $ -0.96 -2.27 %
    Dec 5, 2024
  • 52-Week High/Low
  • $50.04 - $28.7
  • YTD
  • -10.2%

  • Trading Volume
  • 10,254
  • Market Cap Full
  • $ 2.7B
  • Shares Outstanding
  • 65.4M
    Nov 3, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -14.6% -13.1% -48.1% 73.1% 61% -5% 17% -2.1% -9.2% -6.5%
Q2 -31.7% -15.6% -21.3% 89.7% -1% 4% 3.4% -0.5% 7.6% -1.6%
Q3 -28.4% 37.3% -6.4% 37.5% -12.6% 8% -17.9% 18.7% -11.3% -
Q4 -2.7% -4.9% -4.1% -48.9% 49.3% 41.1% 104.5% 9.2% 39.3% -
J F M A M J J A S O N D
2024 -1.8% 4.4% -8.8% -3.7% - - - - - - - -
2023 -0.9% 1% -9.3% 12.6% -4.3% -0.1% -4.1% 5.6% -12.4% -9.3% 18% 25.9%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%-59%-4%-63%123%109%16%103%26%17%-10%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.30 0.23 0.43 -0.21 -0.42 -0.22 -0.42 -0.35 -0.63
Q2 0.07 0.42 0.41 -0.45 -0.37 - -0.51 -0.55 -0.72
Q3 0.27 0.51 0.43 -0.63 -0.33 -0.25 -0.36 -0.57 -0.73
Q4 0.27 0.32 0.45 -0.34 -0.42 -0.34 -0.48 -0.59 -
A 0.9 1.5 1.7 -1.6 -1.5 -0.8 -1.8 -2.1 -2.08

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 25.8 35 35.8 51.9 63
Jun 14.2 25.8 35 41 53.1 63.6
Sep 19.3 25.8 35 41.1 62.3 64.1
Dec 25.2 25.9 35 51.6 62.5 65.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.1 4.5 8 3.5 -
Total Asset Turnover - - 0.2 0.1 -
Leverage
Debt Ratio - - - 0.1 0.1
Debt – Equity Ratio - - - 0.1 0.2
Interest Coverage 32.3 - 15.5 43 12.7
Equity multiplier 0.2 - - - -